Cochlear Implantation in Sporadic Vestibular Schwannoma and Neurofibromatosis Type II

Fiona McClenaghan; Simon Freeman; Simon Lloyd; Emma Stapleton

doi:10.1016/j.otc.2023.02.017

Cochlear Implantation in Sporadic Vestibular Schwannoma and Neurofibromatosis Type II

Fiona McClenaghan, Simon Freeman, Simon Lloyd, Emma Stapleton

Salford Royal NHS Foundation Trust

Research output: Contribution to journal › Review article › peer-review

Abstract

Cochlear implantation offers significantly better hearing outcomes than auditory brainstem implantation in patients with vestibular schwannoma. Neither the primary treatment modality nor the cause of the tumor (neurofibromatosis type 2 related or sporadic) seems to have a significant effect on hearing outcome with cochlear implantation. Some uncertainty remains regarding long-term hearing outcomes; however, cochlear implantation in vestibular schwannoma serves to offer patients, with a functioning cochlear nerve, the probability of open set speech discrimination with a consequent positive impact on quality of life.

Original language	English
Journal	Otolaryngologic Clinics of North America
DOIs	https://doi.org/10.1016/j.otc.2023.02.017
Publication status	E-pub ahead of print - 3 Apr 2023

Access to Document

10.1016/j.otc.2023.02.017

Cite this

@article{165b1f1ceb1c422481ba040499ac22a3,

title = "Cochlear Implantation in Sporadic Vestibular Schwannoma and Neurofibromatosis Type II",

abstract = "Cochlear implantation offers significantly better hearing outcomes than auditory brainstem implantation in patients with vestibular schwannoma. Neither the primary treatment modality nor the cause of the tumor (neurofibromatosis type 2 related or sporadic) seems to have a significant effect on hearing outcome with cochlear implantation. Some uncertainty remains regarding long-term hearing outcomes; however, cochlear implantation in vestibular schwannoma serves to offer patients, with a functioning cochlear nerve, the probability of open set speech discrimination with a consequent positive impact on quality of life.",

author = "Fiona McClenaghan and Simon Freeman and Simon Lloyd and Emma Stapleton",

year = "2023",

month = apr,

day = "3",

doi = "10.1016/j.otc.2023.02.017",

language = "English",

journal = "Otolaryngologic Clinics of North America",

issn = "0030-6665",

publisher = "W.B. Saunders Company",

}

TY - JOUR

T1 - Cochlear Implantation in Sporadic Vestibular Schwannoma and Neurofibromatosis Type II

AU - McClenaghan, Fiona

AU - Freeman, Simon

AU - Lloyd, Simon

AU - Stapleton, Emma

PY - 2023/4/3

Y1 - 2023/4/3

N2 - Cochlear implantation offers significantly better hearing outcomes than auditory brainstem implantation in patients with vestibular schwannoma. Neither the primary treatment modality nor the cause of the tumor (neurofibromatosis type 2 related or sporadic) seems to have a significant effect on hearing outcome with cochlear implantation. Some uncertainty remains regarding long-term hearing outcomes; however, cochlear implantation in vestibular schwannoma serves to offer patients, with a functioning cochlear nerve, the probability of open set speech discrimination with a consequent positive impact on quality of life.

AB - Cochlear implantation offers significantly better hearing outcomes than auditory brainstem implantation in patients with vestibular schwannoma. Neither the primary treatment modality nor the cause of the tumor (neurofibromatosis type 2 related or sporadic) seems to have a significant effect on hearing outcome with cochlear implantation. Some uncertainty remains regarding long-term hearing outcomes; however, cochlear implantation in vestibular schwannoma serves to offer patients, with a functioning cochlear nerve, the probability of open set speech discrimination with a consequent positive impact on quality of life.

U2 - 10.1016/j.otc.2023.02.017

DO - 10.1016/j.otc.2023.02.017

M3 - Review article

C2 - 37019773

SN - 0030-6665

JO - Otolaryngologic Clinics of North America

JF - Otolaryngologic Clinics of North America

ER -

Cochlear Implantation in Sporadic Vestibular Schwannoma and Neurofibromatosis Type II

Abstract

Access to Document

Fingerprint

Cite this